SCHEMBL1413775

SCHEMBL1413775

O=C(NCc1ccc(F)cc1)c1ccc(S(=O)(=O)n2cc(-c3ccncc3F)c3ccccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.48
CXCR4 P61073 1/20 0.47
ROCK2 O75116 2/20 0.46
HTR6 P50406 2/20 0.45
NAMPT P43490 3/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 1/20 0.44
MAPK14 Q16539 1/20 0.44
MAPT P10636 2/20 0.43
TP53 P04637 1/20 0.43
CA2 P00918 1/20 0.43
IDE P14735 1/20 0.43
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1413674 0.89 CXCR4 (0.52) CXCR4HTR6ALDH1A1MAPTCA2
SCHEMBL12810342 0.88 ALDH1A1 (0.49) L3MBTL1CXCR4HTR6NAMPTALDH1A1
SCHEMBL1413819 0.88 HTR6 (0.60) L3MBTL1CXCR4ROCK2HTR6NAMPT
Hydrochloric Acid SCHEMBL1413802 0.88 ALDH1A1 (0.48) L3MBTL1CXCR4HTR6NAMPTALDH1A1
SCHEMBL1413685 0.87 CXCR4 (0.52) L3MBTL1CXCR4HTR6NAMPTALDH1A1
SCHEMBL1413784 0.87 CXCR4 (0.46) L3MBTL1CXCR4ROCK2HTR6NAMPT
SCHEMBL1413889 0.86 CXCR4 (0.48) L3MBTL1CXCR4HTR6NAMPTALDH1A1
SCHEMBL1413309 0.86 HTR6 (0.49) L3MBTL1CXCR4ROCK2HTR6NAMPT
SCHEMBL1413660 0.85 CXCR4 (0.48) L3MBTL1CXCR4HTR6NAMPTALDH1A1
SCHEMBL1413651 0.85 CXCR4 (0.54) L3MBTL1CXCR4HTR6ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1699761-B1 CB1 MODULATOR COMPOUNDS LILLY CO ELI (US) 2011-03-16 EP disclosed
EP-1699761-B1 CB1 MODULATOR COMPOUNDS LILLY CO ELI (US) 2011-03-16 EP disclosed
US-7595339-B2 CB1 modulator compounds ELI LILLY AND COMPANY (US) 2009-09-29 US disclosed
US-7595339-B2 CB1 modulator compounds ELI LILLY AND COMPANY (US) 2009-09-29 US disclosed
US-7595339-B2 CB1 modulator compounds ELI LILLY AND COMPANY (US) 2009-09-29 US disclosed
US-20080287504-A1 CB1 MODULATOR COMPOUNDS ALLEN JENNIFER REBECCA 2008-11-20 US disclosed
US-20080287504-A1 CB1 MODULATOR COMPOUNDS ALLEN JENNIFER REBECCA 2008-11-20 US disclosed
US-20080287504-A1 CB1 MODULATOR COMPOUNDS ALLEN JENNIFER REBECCA 2008-11-20 US disclosed
US-7276516-B2 CB1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-10-02 US disclosed
US-7276516-B2 CB1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-10-02 US disclosed
US-7276516-B2 CB1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-10-02 US disclosed
US-20070088018-A1 Cb1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-04-19 US disclosed
US-20070088018-A1 Cb1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-04-19 US disclosed
US-20070088018-A1 Cb1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088018-A1 Cb1 antagonist compounds CNR1, CNR2, CHRNA5 L3MBTL1 3445/4885CXCR4 690/4885ROCK2 4784/4885
US-20080287504-A1 CB1 MODULATOR COMPOUNDS CNR1, CNR2, MAG L3MBTL1 3496/4885CXCR4 768/4885ROCK2 4782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.